| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 1904 | 2023 |
| Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 KS Ikuta, LR Swetschinski, GR Aguilar, F Sharara, T Mestrovic, AP Gray, ... The Lancet 400 (10369), 2221-2248, 2022 | 1245 | 2022 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 665 | 2022 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 458 | 2024 |
| Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 M Naghavi, SE Vollset, KS Ikuta, LR Swetschinski, AP Gray, EE Wool, ... The Lancet 404 (10459), 1199-1226, 2024 | 337 | 2024 |
| Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 WM Gardner, C Razo, TA McHugh, H Hagins, VM Vilchis-Tella, ... The Lancet Haematology 10 (9), e713-e734, 2023 | 237 | 2023 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 HH Kyu, A Vongpradith, SB Sirota, A Novotney, CE Troeger, MC Doxey, ... The Lancet Infectious Diseases 22 (11), 1626-1647, 2022 | 177 | 2022 |
| A systematic review on drug resistant urinary tract infection among pregnant women in developing countries in Africa and Asia; 2005–2016 MA Belete, M Saravanan Infection and drug resistance, 1465-1477, 2020 | 122 | 2020 |
| The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis B Sartorius, AP Gray, ND Weaver, GR Aguilar, LR Swetschinski, KS Ikuta, ... The Lancet Global Health 12 (2), e201-e216, 2024 | 110 | 2024 |
| Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 HY Wunrow, RG Bender, A Vongpradith, SB Sirota, LR Swetschinski, ... The Lancet Neurology 22 (8), 685-711, 2023 | 74 | 2023 |
| Bacterial profile and ESBL screening of urinary tract infection among asymptomatic and symptomatic pregnant women attending antenatal care of northeastern Ethiopia region MA Belete Infection and Drug Resistance, 2579-2592, 2020 | 58 | 2020 |
| Knowledge, attitude and practice toward covid-19 pandemic among population visiting dessie health center for covid-19 screening, northeast ethiopia D Gebretsadik, S Gebremichael, MA Belete Infection and Drug Resistance, 905-915, 2021 | 53 | 2021 |
| Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021 JR Ledesma, J Ma, M Zhang, AVL Basting, HT Chu, A Vongpradith, ... The Lancet infectious diseases 24 (7), 698-725, 2024 | 34 | 2024 |
| Bacterial profiles and their associated factors of urinary tract infection and detection of extended spectrum beta-lactamase producing gram-negative uropathogens among patients … M Alemu, MA Belete, S Gebreselassie, A Belay, D Gebretsadik Diabetes, Metabolic Syndrome and Obesity, 2935-2948, 2020 | 34 | 2020 |
| The Body-Image concept analysis of youth and adolescent F Alebachew, M Ashagrie American Journal of Biomedical and Life Sciences 5 (6), 130-134, 2017 | 32 | 2017 |
| The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990–2019: a systematic analysis of the Global Burden of Disease … A Brown, MB Ahmed, TG Gebremeskel, GR Naik The Lancet 402 (10398), 313-335, 2023 | 30 | 2023 |
| Prevalence of tuberculosis by automated GeneXpert rifampicin assay and associated risk factors among presumptive pulmonary tuberculosis patients at Ataye District Hospital … D Gebretsadik, N Ahmed, E Kebede, M Mohammed, MA Belete Infection and drug resistance, 1507-1516, 2020 | 29 | 2020 |
| Knowledge, attitude, practice towards COVID-19 pandemic and its prevalence among hospital visitors at Ataye district hospital, Northeast Ethiopia D Gebretsadik, N Ahmed, E Kebede, S Gebremicheal, MA Belete, ... Plos one 16 (2), e0246154, 2021 | 28 | 2021 |
| Prevalence of enteric pathogens, intestinal parasites and resistance profile of bacterial isolates among HIV infected and non-infected diarrheic patients in Dessie Town … A Belay, M Ashagrie, B Seyoum, M Alemu, A Tsegaye PLoS One 15 (12), e0243479, 2020 | 22 | 2020 |
| Emergence of High Prevalence of Extended‐Spectrum Beta‐Lactamase and Carbapenemase‐Producing Enterobacteriaceae Species among Patients in … S Tadesse, W Mulu, C Genet, M Kibret, MA Belete BioMed research international 2022 (1), 5727638, 2022 | 20 | 2022 |
Dr. Saravanan MuthupandianProfessor - FAMS, UT, AMR and NanomedicinePreverjeni e-poštni naslov na ut.edu.sa